Background: Previous studies have revealed increased biological ageing amongst major depressive disorder (MDD) patients, as assayed by shorter leukocyte telomere lengths (TL). Stressors such as childhood maltreatment are more common amongst MDD patients, and it has been suggested that this might contribute to shorter TL present amongst patients. However, to our knowledge, no study has yet tested for reverse causality, i.e. whether a genetic predisposition to shorter TL might predispose to MDD or an earlier onset of MDD.
Introduction
Telomeres are capping structures of tandem TTAGGG nucleotide repeats found at the end of chromosomes (Eitan et al., 2014) . During each cell division, the ends of chromosomes shorten as part of a natural consequence of replication (Aubert and Lansdorp, 2008) . Telomeres function as sacrificial, non-coding DNA buffers, which degrade instead of inward, coding DNA regions (Allsopp et al., 1995) . Eventually, in cells which have undergone many divisions, telomeres become so short that the coding DNA regions within the chromosome are no longer protected, and their degradation triggers the end of that cell's ability to replicate (Eitan et al., 2014) . Telomere length (TL) subsequently acts as marker for 'cellular age' or 'biological age'; with shortened telomeres representing older cells, and commonly, older individuals (Benetos et al., 2001) . However, unlike chronological age, biological ageing can be moderated by environmental and genetic factors (e.g. Tyrka et al., 2010 , Codd et al., 2013 , meaning two unrelated individuals of the same chronological age, may not be the same age biologically. Shortened leukocyte TL, relative to one's age, has been associated with an increased risk to various diseases, generally poorer physical and psychiatric health, and higher mortality (Simon et al., 2006; Fitzpatrick et al., 2007; Kao et al., 2008; Yu et al., 2008; Okereke et al., 2012; Lindqvist et al., 2015; Rode et al., 2015; Darrow et al., 2016) .
Evidence suggests that an increased stress hormone response (cortisol levels), oxidative stress, and immuno-inflammatory activation, could be responsible for some of these inter-individual differences in TL observed within the population (von Zglinicki, 2002; Jurk et al., 2014; Gotlib et al., 2015) . A disease which has been linked to all three of these telomere-eroding factors, is major depressive disorder (MDD; Cowen, 2002; Michel et al., 2012; Martin et al., 2015) . Indeed, most previous studies (e.g. Simon et al., 2006; Lung et al., 2007; Elvsåshagen et al., 2011; Hoen et al., 2011; Garcia-Rizo et al., 2013; Verhoeven et al., 2014) but not all (e.g. Wolkowitz et al., 2011; Teyssier et al., 2012; Needham et al., 2015; Schaakxs et al., 2015) , have revealed shortened leukocyte TL amongst MDD patients with some studies suggesting that shortened TLs may be observed most pervasively in recurrent depressed cases only (e.g. Elvsåshagen et al., 2011) . Interestingly, a history of childhood maltreatment (a risk factor for MDD) also predicts shortened TL in adulthood (Tyrka et al., 2010; O'Donovan et al., 2011; Kananen et al., 2010; Shalev et al., 2014) . This has generated hypotheses which suggest that stress may simultaneously precipitate risk for MDD, and an advancement in telomere shortening; contributing to the increased risk of comorbid ageingrelated disorders present amongst MDD patients; including cardiovascular disease, obesity, and type-2 diabetes (Zhang et al., 2014) . Consequently, it's been hypothesized that negative environmental factors, such as stress, are primarily responsible for shortened leukocyte TL present amongst MDD patients. However, few reports have considered the possibility of reverse causality, i.e. whether a predisposition to advanced biological ageing (i.e. genetic factors) may also predispose an individual to MDD.
A recent genome-wide association study (GWAS) revealed single nucleotide polymorphisms (SNPs) predictive of relative TL; with the two most significant SNPs rs10936599 and rs2736100, located upstream or within the telomerase encoding genes telomerase RNA component (TERC) and telomerase reverse transcriptase (hTERT), respectively (Codd et al., 2013) . These SNPs are hypothesized to affect the functionality of telomerase, an enzyme with the ability to reverse telomere shortening, by adding TTAGGG sequences to the existing telomere ends (Codd et al., 2013) . Thus, SNPs coding for this enzyme represent functionally discrete factors with pervasive effects on longterm TL maintenance. They also represent a means by which we can test if inherent genetic factors influencing TL maintenance predict risk for MDD.
Mendelian randomisation is an 'instrumental variable analysis' and is the formal term used to describe a situation where we test whether genetic factors (a 'instrumental variable') contributing to a biological factor correlating with a disease (e.g. shortened telomere lengths) directly predicts the disease itself (e.g. MDD; Sheehan et al., 2008; Smith and Hermani, 2014) . If it does, this would suggest that the biological correlate may be involved in causing the disease, but if it does not, it may indicate it is an effect of having the disease, or that an independent factor impacts upon both the biological correlate and the disease.
Within this study we adopted a Mendelian randomisation design to investigate whether a genetic predisposition to advanced biological ageing (via rs10936599, rs2736100) predicted an increased risk of recurrent MDD in a large UK sample. As MDD is generally an adultonset disorder (Kessler et al., 2001) and has been repeatedly associated with biological ageing and risk for ageing-related disease (Zhang et al., 2014) , we also tested whether a genetic predisposition to advanced biological ageing might shorten the time it takes for MDD to present itself, i.e. increase risk for childhood (≤12 years old) or childhood/ adolescent-onset (≤17 years old) MDD. These earlier-onset time points were chosen because they represent key, well-characterised, developmental milestones and times during which there are increased rates of cellular division, relative to adulthood. Therefore, phenotypes which result from particular cell populations having a limited proliferative potential (as a result of advanced biological ageing), may begin to precipitate at these earlier time points.
To achieve our aims effectively, we first attempted to replicate Codd and colleagues' findings using relative TL data from an independent cohort (and a subset of our genetic cohort), and to determine the best genetic model and/or combination of the two SNPs (rs10936599 and rs2736100) to use as our 'instrumental variable'. Secondly, using a large UK cohort of 1628 recurrent MDD cases and 1140 control subjects, we tested whether the relative frequency of risk alleles for shorter TL was greater amongst MDD cases, or early-onset MDD cases.
Methods

Subject information
Recurrent MDD cases were recruited from the UK component of RADIANT, described previously (Lewis et al., 2010) . Controls (n=1140) were recruited from the Depression case-control study (n=1040; Cohen-Woods et al., 2009) , and from the South East London Community Health Study (SELCoH, n=100; Hatch et al., 2011) . For a full break down, see Table 1 .
Recurrent MDD cases
RADIANT is an umbrella term for three studies which sought to understand genetic risk for MDD and factors affecting response to treatment; this comprised of the Depression Network (DeNT) study (Farmer et al., 2004) , the Depression Case-Control (DeCC) study (Cohen-Woods et al., 2009) and the Genome-Based Therapeutic Drugs for Depression (GENDEP) study (Uher et al., 2009) . Within these multi-centre clinical studies, we selected only those recruited from the UK who had at least two episodes of major depression of at least moderate severity, in order to create a homogeneous sample. Diagnosis of MDD was ascertained using the Schedules for Clinical Assessment in Neuropsychiatry (SCAN) interview in all three studies 
